Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 708193, 10 pages
http://dx.doi.org/10.1155/2014/708193
Review Article

Ribosomal Alteration-Derived Signals for Cytokine Induction in Mucosal and Systemic Inflammation: Noncanonical Pathways by Ribosomal Inactivation

1Laboratory of Mucosal Exposome and Biomodulation, Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan 626-870, Republic of Korea
2Immunoregulatory Therapeutics Group in Brain Busan 21 Project, Busan 609-735, Republic of Korea
3Medical Research Institute, Pusan National University, Busan 609-735, Republic of Korea

Received 14 September 2013; Accepted 22 November 2013; Published 2 January 2014

Academic Editor: Eduardo López-Collazo

Copyright © 2014 Yuseok Moon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Deisenroth and Y. Zhang, “Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway,” Oncogene, vol. 29, no. 30, pp. 4253–4260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. K. K. Steffen, M. A. McCormick, K. M. Pham et al., “Ribosome deficiency protects against ER stress in Saccharomyces cerevisiae,” Genetics, vol. 191, no. 1, pp. 107–118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Zhang, R. B. Hamanaka, E. Bobrovnikova-Marjon et al., “Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest,” Journal of Biological Chemistry, vol. 281, no. 40, pp. 30036–30045, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Wan, A. Weaver, X. Gao, M. Bern, P. R. Hardwidge, and M. J. Lenardo, “IKKβ 2 phosphorylation regulates RPS3 nuclear translocation and NF-κ B function during infection with Escherichia coli strain O157:H7,” Nature Immunology, vol. 12, no. 4, pp. 335–344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. Wier, J. Neighoff, X. Sun, K. Fu, and F. Wan, “Identification of an N-terminal truncation of the NF-kappaB p65 subunit that specifically modulates ribosomal protein S3-dependent NF-kappaB gene expression,” The Journal of Biological Chemistry, vol. 287, pp. 43019–43029, 2012. View at Google Scholar
  6. H. J. Yang, H. Youn, K. M. Seong, Y. W. Jin, J. Kim, and B. Youn, “Phosphorylation of ribosomal protein S3 and antiapoptotic TRAF2 protein mediates radioresistance in non-small cell lung cancer cells,” The Journal of Biological Chemistry, vol. 288, pp. 2965–2975, 2013. View at Google Scholar
  7. J. Lacadena, E. Álvarez-García, N. Carreras-Sangrà et al., “Fungal ribotoxins: molecular dissection of a family of natural killers,” FEMS Microbiology Reviews, vol. 31, no. 2, pp. 212–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. T. B. Ng, J. H. Wong, and H. Wang, “Recent progress in research on ribosome inactivating proteins,” Current Protein and Peptide Science, vol. 11, no. 1, pp. 37–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Moon, “Mucosal injuries due to ribosome-inactivating stress and the compensatory responses of the intestinal epithelial barrier,” Toxins, vol. 3, no. 10, pp. 1263–1277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Moon, “Cellular alterations of mucosal integrity by ribotoxins: mechanistic implications of environmentally-linked epithelial inflammatory diseases,” Toxicon, vol. 59, no. 1, pp. 192–204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. S. Iordanov, D. Pribnow, J. L. Magun, T.-H. Dinh, J. A. Pearson, and B. E. Magun, “Ultraviolet radiation triggers the ribotoxic stress response in mammalian cells,” Journal of Biological Chemistry, vol. 273, no. 25, pp. 15794–15803, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Li and J. J. Pestka, “Comparative induction of 28S ribosomal RNA cleavage by ricin and the trichothecenes deoxynivalenol and T-2 toxin in the macrophage,” Toxicological Sciences, vol. 105, no. 1, pp. 67–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Bunyard, M. Handley, G. Pollara et al., “Ribotoxic stress activates p38 and JNK kinases and modulates the antigen-presenting activity of dendritic cells,” Molecular Immunology, vol. 39, no. 13, pp. 815–827, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Instanes and G. Hetland, “Deoxynivalenol (DON) is toxic to human colonic, lung and monocytic cell lines, but does not increase the IgE response in a mouse model for allergy,” Toxicology, vol. 204, no. 1, pp. 13–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. W. E. Smith, A. V. Kane, S. T. Campbell, D. W. K. Acheson, B. H. Cochran, and C. M. Thorpe, “Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells,” Infection and Immunity, vol. 71, no. 3, pp. 1497–1504, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Braune, D. Wichmann, M.C. von Heinz et al., “Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome,” Critical Care Medicine, vol. 41, no. 7, pp. 1702–1710, 2013. View at Publisher · View at Google Scholar
  17. V. Korcheva, J. Wong, C. Corless, M. Iordanov, and B. Magun, “Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and p38 MAPK and provides a mouse model of hemolytic uremic syndrome,” American Journal of Pathology, vol. 166, no. 1, pp. 323–339, 2005. View at Google Scholar · View at Scopus
  18. Y. Luo, T. Yoshizawa, and T. Katayama, “Comparative study on the natural occurrence of Fusarium mycotoxins (trichothecenes and zearalenone) in corn and wheat from high- and low-risk areas for human esophageal cancer in China,” Applied and Environmental Microbiology, vol. 56, no. 12, pp. 3723–3726, 1990. View at Google Scholar · View at Scopus
  19. F.-Q. Li, Y.-W. Li, X.-Y. Luo, and T. Yoshizawa, “Fusarium toxins in wheat from an area in Henan Province, PR China, with a previous human red mould intoxication episode,” Food Additives and Contaminants, vol. 19, no. 2, pp. 163–167, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. R. V. Bhat, S. R. Beedu, Y. Ramakrishna, and K. L. Munshi, “Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India,” The Lancet, vol. 1, pp. 35–37, 1989. View at Google Scholar
  21. J. M. Yoder, R. U. Aslam, and N. J. Mantis, “Evidence for widespread epithelial damage and coincident production of monocyte chemotactic protein 1 in a murine model of intestinal ricin intoxication,” Infection and Immunity, vol. 75, no. 4, pp. 1745–1750, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Thorpe, B. P. Hurley, L. L. Lincicome, M. S. Jacewicz, G. T. Keusch, and D. W. K. Acheson, “Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells,” Infection and Immunity, vol. 67, no. 11, pp. 5985–5993, 1999. View at Google Scholar · View at Scopus
  23. C. J. Amuzie, Z. Islam, J. K. Kim, J.-H. Seo, and J. J. Pestka, “Kinetics of satratoxin G tissue distribution and excretion following intranasal exposure in the mouse,” Toxicological Sciences, vol. 116, no. 2, pp. 433–440, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. A. Carey, C. G. Plopper, D. M. Hyde, Z. Islam, J. J. Pestka, and J. R. Harkema, “Satratoxin-G from the black mold Stachybotrys chartarum induces rhinitis and apoptosis of olfactory sensory neurons in the nasal airways of rhesus monkeys,” Toxicologic Pathology, vol. 40, pp. 887–898, 2012. View at Google Scholar
  25. K. N. Corps, Z. Islam, J. J. Pestka, and J. R. Harkema, “Neurotoxic, inflammatory, and mucosecretory responses in the nasal airways of mice repeatedly exposed to the macrocyclic trichothecene mycotoxin roridin A: dose-response and persistence of injury,” Toxicologic Pathology, vol. 38, no. 3, pp. 429–451, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Islam, C. J. Amuzie, J. R. Harkema, and J. J. Pestka, “Neurotoxicity and inflammation in the nasal airways of mice exposed to the Macrocyclic trichothecene mycotoxin roridin A: kinetics and potentiation by bacterial lipopolysaccharide coexposure,” Toxicological Sciences, vol. 98, no. 2, pp. 526–541, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Moon, H. Yang, and S.-H. Park, “Hypo-responsiveness of interleukin-8 production in human embryonic epithelial intestine 407 cells independent of NF-κB pathway: new lessons from endotoxin and ribotoxic deoxynivalenol,” Toxicology and Applied Pharmacology, vol. 231, no. 1, pp. 94–102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-H. Park, H. J. Choi, H. Yang, K. H. Do, J. Kim, and Y. Moon, “Repression of peroxisome proliferator-activated receptor γ by mucosal ribotoxic insult-activated CCAAT/enhancer-binding protein homologous protein,” Journal of Immunology, vol. 185, no. 9, pp. 5522–5530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-R. Zhou, J. R. Harkema, D. Yan, and J. J. Pestka, “Amplified proinflammatory cytokine expression and toxicity in mice coexposed to lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol),” Journal of Toxicology and Environmental Health A, vol. 57, no. 2, pp. 115–136, 1999. View at Google Scholar · View at Scopus
  30. H.-R. Zhou, Q. Jia, and J. J. Pestka, “Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the Src family kinase Hck,” Toxicological Sciences, vol. 85, no. 2, pp. 916–926, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Rzymski and A. L. Harris, “The unfolded protein response and integrated stress response to anoxia,” Clinical Cancer Research, vol. 13, no. 9, pp. 2537–2540, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. J. D. Laskin, D. E. Heck, and D. L. Laskin, “The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity,” Toxicological Sciences, vol. 69, no. 2, pp. 289–291, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. V. I. Shifrin and P. Anderson, “Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis,” Journal of Biological Chemistry, vol. 274, no. 20, pp. 13985–13992, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. M. S. Iordanov, R. J. Choi, O. P. Ryabinina, T.-H. Dinh, R. K. Bright, and B. E. Magun, “The UV (ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor,” Molecular and Cellular Biology, vol. 22, no. 15, pp. 5380–5394, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. F. A. Braz, J. S. Cruz, A. C. Faria-Campos, and S. V. Campos, “Probabilistic model checking analysis of palytoxin effects on cell energy reactions of the Na+/K+-ATPase,” IEEE Transactions on Computational Biology and Bioinformatics. In press.
  36. S. Ficarra, A. Russo, F. Stefanizzi et al., “Palytoxin induces functional changes of anion transport in red blood cells: metabolic impact,” Journal of Membrane Biology, vol. 242, no. 1, pp. 31–39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. E. V. Wattenberg, “Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis,” American Journal of Physiology: Cell Physiology, vol. 292, no. 1, pp. C24–C32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Crinelli et al., “Palytoxin and an Ostreopsis toxin extract increase the levels of mRNAs encoding inflammation-related proteins in human macrophages via p38 MAPK and NF-kappaB,” PLoS ONE, vol. 7, Article ID e38139, 2012. View at Publisher · View at Google Scholar
  39. T. B. El-Abaseri, B. Hammiller, S. K. Repertinger, and L. A. Hansen, “The epidermal growth factor receptor increases cytokine production and cutaneous inflammation in response to ultraviolet irradiation,” ISRN Dermatology, vol. 2013, Article ID 848705, 11 pages, 2013. View at Publisher · View at Google Scholar
  40. H. Bae, J. S. Gray, M. Li, L. Vines, J. Kim, and J. J. Pestka, “Hematopoietic cell kinase associates with the 40S ribosomal subunit and mediates the ribotoxic stress response to deoxynivalenol in mononuclear phagocytes,” Toxicological Sciences, vol. 115, no. 2, pp. 444–452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. S. Gray, H. K. Bae, J. C. B. Li, A. S. Lau, and J. J. Pestka, “Double-stranded RNA—activated protein kinase mediates induction of interleukin-8 expression by deoxynivalenol, shiga toxin 1, and ricin in monocytes,” Toxicological Sciences, vol. 105, no. 2, pp. 322–330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. K. He, H. R. Zhou, and J. J. Pestka, “Mechanisms for ribotoxin-induced ribosomal RNA cleavage,” Toxicology and Applied Pharmacology, vol. 265, no. 1, pp. 10–18, 2012. View at Google Scholar
  43. J. Deng, H. P. Harding, B. Raught et al., “Activation of gcn2 in uv-irradiated cells inhibits translation,” Current Biology, vol. 12, no. 15, pp. 1279–1286, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. S.-Y. Lee, M.-S. Lee, R. P. Cherla, and V. L. Tesh, “Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells,” Cellular Microbiology, vol. 10, no. 3, pp. 770–780, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. O. Donzé, J. Deng, J. Curran, R. Sladek, D. Picard, and N. Sonenberg, “The protein kinase PKR: a molecular clock that sequentially activates survival and death programs,” The EMBO Journal, vol. 23, no. 3, pp. 564–571, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Malmgaard, “Induction and regulation of IFNs during viral infections,” Journal of Interferon and Cytokine Research, vol. 24, no. 8, pp. 439–454, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Pindel and A. Sadler, “The role of protein kinase R in the interferon response,” Journal of Interferon and Cytokine Research, vol. 31, no. 1, pp. 59–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Meurs, K. Chong, J. Galabru et al., “Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon,” Cell, vol. 62, no. 2, pp. 379–390, 1990. View at Publisher · View at Google Scholar · View at Scopus
  49. K. He, H. R. Zhou, and J. J. Pestka, “Targets and intracellular signaling mechanisms for deoxynivalenol-induced ribosomal RNA cleavage,” Toxicological Sciences, vol. 127, pp. 382–390, 2012. View at Google Scholar
  50. H.-R. Zhou, A. S. Lau, and J. J. Pestka, “Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response,” Toxicological Sciences, vol. 74, no. 2, pp. 335–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Li, J. R. Harkema, C. F. Cuff, and J. J. Pestka, “Deoxynivalenol exacerbates viral bronchopneumonia induced by respiratory reovirus infection,” Toxicological Sciences, vol. 95, no. 2, pp. 412–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. S.-H. Park, H. J. Choi, H. Yang, K. H. Do, J. Kim, and Y. Moon, “Repression of peroxisome proliferator-activated receptor γ by mucosal ribotoxic insult-activated CCAAT/enhancer-binding protein homologous protein,” Journal of Immunology, vol. 185, no. 9, pp. 5522–5530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Yang, S. H. Park, H. J. Choi et al., “Mechanism-based alternative monitoring of endoplasmic reticulum stress by 8-keto-trichothecene mycotoxins using human intestinal epithelial cell line,” Toxicology Letters, vol. 198, no. 3, pp. 317–323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. B. A. Parikh, A. Tortora, X.-P. Li, and N. E. Tumer, “Ricin inhibits activation of the unfolded protein response by preventing splicing of the HAC1 mRNA,” Journal of Biological Chemistry, vol. 283, no. 10, pp. 6145–6153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Shi, K. Porter, N. Parameswaran, H. K. Bae, and J. J. Pestka, “Role of GRP78/BiP degradation and ER stress in deoxynivalenol-induced interleukin-6 upregulation in the macrophage,” Toxicological Sciences, vol. 109, no. 2, pp. 247–255, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. V. L. Tesh, “Activation of cell stress response pathways by Shiga toxins,” Cellular Microbiology, vol. 14, no. 1, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. P. J. Kahle and C. Haass, “How does parkin ligate ubiquitin to Parkinson's disease? First in molecular medicine review series,” EMBO Reports, vol. 5, no. 7, pp. 681–685, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Araki, S. Oyadomari, and M. Mori, “Endoplasmic reticulum stress and diabetes mellitus,” Internal Medicine, vol. 42, no. 1, pp. 7–14, 2003. View at Google Scholar · View at Scopus
  59. W. Lin, H. P. Harding, D. Ron, and B. Popko, “Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-γ,” Journal of Cell Biology, vol. 169, no. 4, pp. 603–612, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Lesage, H. Zouali, J.-P. Cézard et al., “CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease,” American Journal of Human Genetics, vol. 70, no. 4, pp. 845–857, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Katschinski, R. F. A. Logan, M. Edmond, and M. J. S. Langman, “Smoking and sugar intake are separate but interactive risk factors in Crohn's disease,” Gut, vol. 29, no. 9, pp. 1202–1206, 1988. View at Google Scholar · View at Scopus
  62. S. M. Collins, “Stress and the gastrointestinal tract IV. Modulation of intestinal inflammation by stress: basic mechanisms and clinical relevance,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 280, no. 3, pp. G315–G318, 2001. View at Google Scholar · View at Scopus
  63. M. Campieri and P. Gionchetti, “Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?” Gastroenterology, vol. 116, no. 5, pp. 1246–1249, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Baban, J. Y. Liu, and M. S. Mozaffari, “Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: role of indoleamine 2,3-dioxygenase and programmed death-1,” Experimental and Molecular Pathology, vol. 94, pp. 343–351, 2012. View at Google Scholar
  65. M. Kitamura, “Control of NF-kappaB and inflammation by the unfolded protein response,” International Reviews of Immunology, vol. 30, pp. 4–15, 2011. View at Google Scholar
  66. A. B. Tam, E. L. Mercado, A. Hoffmann, and M. Niwa, “ER stress activates NF-kappaB by integrating functions of basal IKK activity, IRE1 and PERK,” PLoS ONE, vol. 7, Article ID e45078, 2012. View at Publisher · View at Google Scholar
  67. A. D. Garg, A. Kaczmarek, O. Krysko, P. Vandenabeele, D. V. Krysko, and P. Agostinis, “ER stress-induced inflammation: does it aid or impede disease progression?” Trends in Molecular Medicine, vol. 18, pp. 589–598, 2012. View at Google Scholar
  68. K. H. Do, H. J. Choi, J. Kim et al., “Ambivalent roles of early growth response 1 in inflammatory signaling following ribosomal insult in human enterocytes,” Biochemical Pharmacology, vol. 84, pp. 513–521, 2012. View at Google Scholar
  69. S. H. Park, K. H. Do, H. J. Choi et al., “Novel regulatory action of ribosomal inactivation on epithelial Nod2-linked proinflammatory signals in two convergent ATF3-associated pathways,” The Journal of Immunology, vol. 191, pp. 5170–5181, 2013. View at Google Scholar
  70. Y. Moon, H. Yang, and S. H. Lee, “Modulation of early growth response gene 1 and interleukin-8 expression by ribotoxin deoxynivalenol (vomitoxin) via ERK1/2 in human epithelial intestine 407 cells,” Biochemical and Biophysical Research Communications, vol. 362, no. 2, pp. 256–262, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. S.-H. Park, H. J. Choi, H. Yang, K. H. Do, J. Kim, and Y. Moon, “Repression of peroxisome proliferator-activated receptor γ by mucosal ribotoxic insult-activated CCAAT/enhancer-binding protein homologous protein,” Journal of Immunology, vol. 185, no. 9, pp. 5522–5530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Endo, M. Mori, S. Akira, and T. Gotoh, “C/EBP homologous protein (CHOP) is crucial for the induction of caspase-11 and the pathogenesis of lipopolysaccharide-induced inflammation,” Journal of Immunology, vol. 176, no. 10, pp. 6245–6253, 2006. View at Google Scholar · View at Scopus
  73. T. Namba, K.-I. Tanaka, Y. Ito et al., “Positive role of CCAAT/enhancer-binding protein homologous protein, a transcription factor involved in the endoplasmic reticulum stress response in the development of colitis,” American Journal of Pathology, vol. 174, no. 5, pp. 1786–1798, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. Z. Wu, Y. Xie, N. L. R. Bucher, and S. R. Farmer, “Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis,” Genes and Development, vol. 9, no. 19, pp. 2350–2363, 1995. View at Google Scholar · View at Scopus
  75. Y. Zhu, C. Qi, J. R. Korenberg et al., “Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 17, pp. 7921–7925, 1995. View at Publisher · View at Google Scholar · View at Scopus
  76. S.-H. Park, H. J. Choi, H. Yang et al., “Endoplasmic reticulum stress-activated C/EBP homologous protein enhances nuclear factor-κB signals via repression of peroxisome proliferator-activated receptor,” Journal of Biological Chemistry, vol. 285, no. 46, pp. 35330–35339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. D. M. Jandhyala, T. J. Rogers, A. Kane, A. W. Paton, J. C. Paton, and C. M. Thorpe, “Shiga toxin 2 and flagellin from Shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation,” Infection and Immunity, vol. 78, no. 7, pp. 2984–2994, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Sakiri, B. Ramegowda, and V. L. Tesh, “Shiga toxin type 1 activates tumor necrosis factor-α gene transcription and nuclear translocation of the transcriptional activators nuclear factor- κB and activator protein-1,” Blood, vol. 92, no. 2, pp. 558–566, 1998. View at Google Scholar · View at Scopus
  79. J. Van De Walle, A. During, N. Piront, O. Toussaint, Y.-J. Schneider, and Y. Larondelle, “Physio-pathological parameters affect the activation of inflammatory pathways by deoxynivalenol in Caco-2 cells,” Toxicology in Vitro, vol. 24, no. 7, pp. 1890–1898, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. N. Hauf and T. Chakraborty, “Suppression of NF-κB activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli,” Journal of Immunology, vol. 170, no. 4, pp. 2074–2082, 2003. View at Google Scholar · View at Scopus
  81. H. Sugimoto, T. Kataoka, M. Igarashi, M. Hamada, T. Takeuchi, and K. Nagai, “E-73, an acetoxyl analogue of cycloheximide, blocks the tumor necrosis factor-induced NF-κB signaling pathway,” Biochemical and Biophysical Research Communications, vol. 277, no. 2, pp. 330–333, 2000. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Fu, J. Zhang, Y. Lin, X. Zhu, M. U. Ehrengruber, and Y. E. Chen, “Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-γ1 gene expression in human aortic smooth muscle cells,” Journal of Biological Chemistry, vol. 277, no. 30, pp. 26808–26814, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Okada, S. F. Yan, and D. J. Pinsky, “Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets,” The FASEB Journal, vol. 16, no. 14, pp. 1861–1868, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Zhou, X. Jia, M. Zhou, and J. Liu, “Egr-1 is involved in the inhibitory effect of leptin on PPARγ expression in hepatic stellate cell in vitro,” Life Sciences, vol. 84, no. 15-16, pp. 544–551, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Adachi, R. Kurotani, K. Morimura et al., “Peroxisome proliferator activated receptor γ in colonic epithelial cells protects against experimental inflammatory bowel disease,” Gut, vol. 55, no. 8, pp. 1104–1113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. L. Dubuquoy, E. Å Jansson, S. Deeb et al., “Impaired expression of peroxisome proliferator-activated receptor γin ulcerative colitis,” Gastroenterology, vol. 124, no. 5, pp. 1265–1276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. L. Dubuquoy, C. Rousseaux, X. Thuru et al., “PPARγ as a new therapeutic target in inflammatory bowel diseases,” Gut, vol. 55, no. 9, pp. 1341–1349, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Jiang, A. T. Ting, and B. Seed, “PPAR-γ agonists inhibit production of monocyte inflammatory cytokines,” Nature, vol. 391, no. 6662, pp. 82–86, 1998. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass, “The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation,” Nature, vol. 391, no. 6662, pp. 79–82, 1998. View at Publisher · View at Google Scholar · View at Scopus
  90. Y. Barak, M. C. Nelson, E. S. Ong et al., “PPARγ is required for placental, cardiac, and adipose tissue development,” Molecular Cell, vol. 4, no. 4, pp. 585–595, 1999. View at Publisher · View at Google Scholar · View at Scopus
  91. D. Kelly, J. I. Campbell, T. P. King et al., “Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shutting of PPAR-γ and ReIA,” Nature Immunology, vol. 5, no. 1, pp. 104–112, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. A. von Knethen, M. Soller, N. Tzieply et al., “PPARγ1 attenuates cytosol to membrane translocation of PKCα to desensitize monocytes/macrophages,” Journal of Cell Biology, vol. 176, no. 5, pp. 681–694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. H. J. Choi, H. Yang, S. H. Park, and Y. Moon, “HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol,” Toxicology and Applied Pharmacology, vol. 240, no. 1, pp. 46–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. Y.-J. Chung, H.-R. Zhou, and J. J. Pestka, “Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-α expression by deoxynivalenol (vomitoxin),” Toxicology and Applied Pharmacology, vol. 193, no. 2, pp. 188–201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. S. H. Park, H. J. Choi, H. Yang et al., “Two in-and-out modulation strategies for endoplasmic reticulum stress-linked gene expression of pro-apoptotic macrophage-inhibitory cytokine 1,” The Journal of Biological Chemistry, vol. 287, no. 24, pp. 19841–19855, 2012. View at Publisher · View at Google Scholar
  96. P. Anderson and N. Kedersha, “Stressful initiations,” Journal of Cell Science, vol. 115, no. 16, pp. 3227–3234, 2002. View at Google Scholar · View at Scopus
  97. S. Hu, E. C. Claud, M. W. Musch, and E. B. Chang, “Stress granule formation mediates the inhibition of colonic Hsp70 translation by interferon-γ and tumor necrosis factor-α,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 298, no. 5, pp. G795–G796, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Mazroui, R. Sukarieh, M.-E. Bordeleau et al., “Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2α phosphorylation,” Molecular Biology of the Cell, vol. 17, no. 10, pp. 4212–4219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Mokas, J. R. Mills, C. Garreau et al., “Uncoupling stress granule assembly and translation initiation inhibition,” Molecular Biology of the Cell, vol. 20, no. 11, pp. 2673–2683, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. J. Fan, F. T. Ishmael, X. Fang et al., “Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium,” Journal of Immunology, vol. 186, no. 4, pp. 2482–2494, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Feng, W. Chen, D. Cao et al., “Involvement of Na+, K+-ATPase and its inhibitors in HuR-mediated cytokine mRNA stabilization in lung epithelial cells,” Cellular and Molecular Life Sciences, vol. 68, no. 1, pp. 109–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. S. H. Park, H. J. Choi, K. H. Do, H. Yang, J. Kim, and Y. Moon, “Chronic Nod2 stimulation potentiates activating transcription factor 3 and paradoxical superinduction of epithelial proinflammatory chemokines by mucoactive ribotoxic stressors via RNA-binding protein human antigen R,” Toxicological Sciences, vol. 125, no. 1, pp. 116–125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  103. E.-Y. Choi, Z.-Y. Park, E.-J. Choi et al., “Transcriptional regulation of IL-8 by iron chelator in human epithelial cells is independent from NF-κB but involves ERK1/2- and p38 kinase-dependent activation of AP-1,” Journal of Cellular Biochemistry, vol. 102, no. 6, pp. 1442–1457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. L. Agostini, F. Martinon, K. Burns, M. F. McDermott, P. N. Hawkins, and J. Tschopp, “NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder,” Immunity, vol. 20, no. 3, pp. 319–325, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. F. Martinon, K. Burns, and J. Tschopp, “The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β,” Molecular Cell, vol. 10, no. 2, pp. 417–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  106. S. M. Srinivasula, J.-L. Poyet, M. Razmara, P. Datta, Z. Zhang, and E. S. Alnemri, “The PYRIN-CARD protein ASC is an activating adaptor for caspase-1,” Journal of Biological Chemistry, vol. 277, no. 24, pp. 21119–21122, 2002. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Lindauer, J. Wong, and B. Magun, “Ricin toxin activates the NALP3 inflammasome,” Toxins, vol. 2, no. 6, pp. 1500–1514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. M. L. Vyleta, J. Wong, and B. E. Magun, “Suppression of ribosomal function triggers innate immune signaling through activation of the NLRP3 inflammasome,” PLoS ONE, vol. 7, Article ID e36044, 2012. View at Publisher · View at Google Scholar
  109. J. W. Yu, A. Farias, I. Hwang, T. Fernandes-Alnemri, and E. S. Alnemri, “Ribotoxic stress through p38 mitogen-activated protein kinase activates in vitro the human pyrin inflammasome,” The Journal of Biological Chemistry, vol. 288, pp. 11378–11383, 2013. View at Google Scholar
  110. M. L. Lindauer, J. Wong, Y. Iwakura, and B. E. Magun, “Pulmonary inflammation triggered by ricin toxin requires macrophages and IL-1 signaling,” Journal of Immunology, vol. 183, no. 2, pp. 1419–1426, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. D. M. Jandhyala, C. M. Thorpe, and B. Magun, “Ricin and Shiga toxins: effects on host cell Signal transduction,” Current Topics in Microbiology and Immunology, vol. 357, pp. 41–65, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. E. Díaz-Rodríguez, J. C. Montero, A. Esparís-Ogando, L. Yuste, and A. Pandiella, “Extracellular signal-regulated kinase phosphorylates tumor necrosis factor α-converting enzyme at threonine 735: a potential role in regulated shedding,” Molecular Biology of the Cell, vol. 13, no. 6, pp. 2031–2044, 2002. View at Publisher · View at Google Scholar · View at Scopus
  113. P. Xu, J. Liu, M. Sakaki-Yumoto, and R. Derynck, “TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association,” Science Signaling, vol. 5, article ra34, 2012. View at Google Scholar
  114. J. C. Montero, L. Yuste, E. Díaz-Rodríguez, A. Esparís-Ogando, and A. Pandiella, “Mitogen-activated protein kinase-dependent and -independent routes control shedding of transmembrane growth factors through multiple secretases,” Biochemical Journal, vol. 363, no. 2, pp. 211–221, 2002. View at Publisher · View at Google Scholar · View at Scopus
  115. A. J. Scott, K. P. O'Dea, D. O'Callaghan et al., “Reactive oxygen species and p38 mitogen-activated protein kinase mediate tumor necrosis factor α-converting enzyme (TACE/ADAM-17) activation in primary human monocytes,” Journal of Biological Chemistry, vol. 286, no. 41, pp. 35466–35476, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Hirano and T. Kataoka, “Deoxynivalenol induces ectodomain shedding of TNF receptor 1 and thereby inhibits the TNF-alpha-induced NF-kappaB signaling pathway,” European Journal of Pharmacology, vol. 701, pp. 144–151, 2013. View at Google Scholar
  117. Y. Yamada, S. Taketani, H. Osada, and T. Kataoka, “Cytotrienin A, a translation inhibitor that induces ectodomain shedding of TNF receptor 1 via activation of ERK and p38 MAP kinase,” European Journal of Pharmacology, vol. 667, no. 1–3, pp. 113–119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. C. Becker-Pauly and S. Rose-John, “TNFalpha cleavage beyond TACE/ADAM17: matrix metalloproteinase 13 is a potential therapeutic target in sepsis and colitis,” EMBO Molecular Medicine, vol. 5, pp. 902–904, 2013. View at Google Scholar
  119. S. Rose-John, “ADAM17, shedding, TACE as therapeutic targets,” Pharmacological Research, vol. 71, pp. 19–22, 2013. View at Google Scholar